HCV test kit Aptima®

for infectious diseasesclinicalreal-time

Confirmation of active HCV infection and monitoring HCV viral load on the fully automated Panther® system. Demand More from Your HCV NAAT The Aptima HCV Quant Dx assay detects and quantitates HCV RNA and is intended for use as an aid in: Diagnosis of active HCV infection following a positive HCV antibody test Clinical management of patients infected with HCV The Aptima HCV Quant Dx Assay intended use is to: Confirm HCV Infection Detects and quantitates HCV RNA genotypes 1, 2, 3, 4, 5, and 6. Monitor Viral Load Provides industry-leading sensitivity in even the lowest-level HCV concentrations. HCV Treatment Is Evolving. Now HCV Testing Is Too. The Aptima HCV Quant Dx assay meets the 2021 American Association for the Study of Liver Diseases (AASLD) recommendations for an FDA-approved quantitative or qualitative nucleic acid test (LoD ≤25 IU/mL) to determine sustained virological response (SVR). It employs real-time transcription-mediated amplification (RT-TMA) technology on Hologic’s Panther® system—and gives you unparalleled performance across several essential parameters. Performance by design The robust design of the Aptima HCV Quant Dx assay incorporates multiple primers and probes within a highly conserved region of HCV RNA (5’ UTR) to detect and quantitate across genotypes 1 – 6:1 Redundant target capture oligos for protection against mutations Longer oligos for extra protection against single-base mismatches Multiple amplification primers (T7 and non-T7) for broad genotype coverage Redefining sensitivity: Detect even the lowest-level concentrations of HCV across all major genotypes and quantify HCV for optimal treatment monitoring.